| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabriel Xavier-Souza, Ana Luisa Vilas-Boas, Maria-Socorro Heitz Fontoura, César Augusto Araújo-Neto, Sandra C S Andrade, Maria-Regina Alves Cardoso, Cristiana Maria Nascimento-Carvalh. The inter-observer variation of chest radiograph reading in acute lower respiratory tract infection among children. Pediatric pulmonology. vol 48. issue 5. 2013-11-01. PMID:22888091. |
concordance for consolidation was 86.7% (k = 0.683, 95%ci: 0.631-0.741). |
2013-11-01 |
2023-08-12 |
Not clear |
| Qaiser Bashir, Hassan Khan, Robert Z Orlowski, Ali Imran Amjad, Nina Shah, Simrit Parmar, Wei Wei, Gabriela Rondon, Donna M Weber, Michael Wang, Sheeba K Thomas, Jatin J Shah, Sofia R Qureshi, Yvonne T Dinh, Uday Popat, Paolo Anderlini, Chitra Hosing, Sergio Giralt, Richard E Champlin, Muzaffar H Qazilbas. Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma. American journal of hematology. vol 87. issue 3. 2012-05-07. PMID:22231283. |
in multivariate analysis, allo-hct for primary remission consolidation was associated with longer pfs (hr 0.35; 95% ci, 0.18-0.67) and os (hr 0.29; 95% ci 0.15-0.55), while absence of high-risk cytogenetics was associated with longer pfs only (hr 0.59; 95% ci 0.37-0.95). |
2012-05-07 |
2023-08-12 |
Not clear |
| Hao Wang, Xiao-yuan Chen, Bai-song Wang, Zheng-xing Rong, Hong Qi, Hong-zhuan Che. The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis. Leukemia research. vol 35. issue 9. 2011-11-08. PMID:21774985. |
compared with ato alone, induction therapy with ato/atra significantly increased the complete remission (cr) rate (rr: 1.08, 95% ci: 1.00-1.17, p=0.04), shortened the time to achieve cr (wmd: -6.51, 95% ci: -11.32 to -1.70, p=0.008), and improved the molecular remission rate after consolidation therapy (rr: 1.74, 95% ci: 1.14-2.66, p=0.01) and the 1-year disease-free survival rate (rr: 1.22, 95% ci: 1.00-1.50, p=0.05). |
2011-11-08 |
2023-08-12 |
Not clear |
| Shinji Kishi, Cheng Cheng, Deborah French, Deqing Pei, Soma Das, Edwin H Cook, Nobuko Hijiya, Carmelo Rizzari, Gary L Rosner, Tony Frudakis, Ching-Hon Pui, William E Evans, Mary V Rellin. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. vol 109. issue 10. 2007-07-12. PMID:17264302. |
during the consolidation phase, when antifolates predominated, the reduced folate carrier polymorphism predicted gastrointestinal toxicity (or, 10.4 [95% ci, 1.35-80.4]) as it also did during continuation (or, 2.01 [95% ci, 1.06-4.11]). |
2007-07-12 |
2023-08-12 |
human |
| Martin S Tallman, Waleska S Pérez, Hillard M Lazarus, Robert Peter Gale, Richard T Maziarz, Jacob M Rowe, David I Marks, Jean-Yves Cahn, Asad Bashey, Michael R Bishop, Neal Christiansen, Stanley R Frankel, Juan J García, Osman Ilhan, Mary J Laughlin, Jane Liesveld, Charles Linker, Mark R Litzow, Selina Luger, Philip L McCarthy, Gustavo A Milone, Santiago Pavlovsky, Gordon L Phillips, James A Russell, Ruben A Saez, Gary Schiller, Jorge Sierra, Roy S Weiner, Axel R Zander, Mei-Jie Zhang, Armand Keating, Daniel J Weisdorf, Mary M Horowit. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. vol 12. issue 2. 2006-12-22. PMID:16443518. |
five-year relapse rates were 49% (95% confidence interval ci} = 39%-58%) with no consolidation, 35% (95% ci = 29%-42%) with standard-dose cytarabine, and 40% (95% ci = 33%-48%) with high-dose cytarabine (p = .07). |
2006-12-22 |
2023-08-12 |
Not clear |
| Martin S Tallman, Waleska S Pérez, Hillard M Lazarus, Robert Peter Gale, Richard T Maziarz, Jacob M Rowe, David I Marks, Jean-Yves Cahn, Asad Bashey, Michael R Bishop, Neal Christiansen, Stanley R Frankel, Juan J García, Osman Ilhan, Mary J Laughlin, Jane Liesveld, Charles Linker, Mark R Litzow, Selina Luger, Philip L McCarthy, Gustavo A Milone, Santiago Pavlovsky, Gordon L Phillips, James A Russell, Ruben A Saez, Gary Schiller, Jorge Sierra, Roy S Weiner, Axel R Zander, Mei-Jie Zhang, Armand Keating, Daniel J Weisdorf, Mary M Horowit. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. vol 12. issue 2. 2006-12-22. PMID:16443518. |
five-year leukemia-free survival rates were 39% (95% ci = 30%-47%) with no consolidation, 53% (95% ci = 46%-60%) with standard-dose cytarabine, and 48% (95% ci = 40%-56%) with high-dose cytarabine (p = .03). |
2006-12-22 |
2023-08-12 |
Not clear |
| Martin S Tallman, Waleska S Pérez, Hillard M Lazarus, Robert Peter Gale, Richard T Maziarz, Jacob M Rowe, David I Marks, Jean-Yves Cahn, Asad Bashey, Michael R Bishop, Neal Christiansen, Stanley R Frankel, Juan J García, Osman Ilhan, Mary J Laughlin, Jane Liesveld, Charles Linker, Mark R Litzow, Selina Luger, Philip L McCarthy, Gustavo A Milone, Santiago Pavlovsky, Gordon L Phillips, James A Russell, Ruben A Saez, Gary Schiller, Jorge Sierra, Roy S Weiner, Axel R Zander, Mei-Jie Zhang, Armand Keating, Daniel J Weisdorf, Mary M Horowit. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. vol 12. issue 2. 2006-12-22. PMID:16443518. |
similarly, 5-year overall survival was better in those patients receiving consolidation: 42% (95% ci = 34%-51%) with no consolidation, 59% (95% ci = 52%-65%) with standard-dose cytarabine, and 54% (95% ci = 46%-61%) with high-dose cytarabine (p = .01). |
2006-12-22 |
2023-08-12 |
Not clear |
| R J Boots, J Lipman, R Bellomo, D Stephens, R E Helle. The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesthesia and intensive care. vol 33. issue 1. 2005-09-08. PMID:15957698. |
bronchoscopy was performed in 26%, its use predicted by admission hospital (one tertiary: or 9.98, ci 95% 5.11-19.49, p< 0.001; one regional: or 6.29, ci 95% 3.24-12.20, p<0.001), clinical signs of consolidation (or 3.72, ci 95% 2.09-6.62, p<0.001) and diagnostic confidence (or 2.19, ci 95% 1.29-3.72, p=0.004). |
2005-09-08 |
2023-08-12 |
Not clear |
| R J Boots, J Lipman, R Bellomo, D Stephens, R F Helle. Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesthesia and intensive care. vol 33. issue 1. 2005-09-08. PMID:15957699. |
for community acquired pneumonia, mortality increased with immunosuppression (or 5.32, ci 95% 1.58-1799, p<0.01), clinical signs of consolidation (or 2.43, ci 95% 1.09-5.44, p=0.03) and sepsis-related organ failure assessment (sofa) scores (or 1.19, ci 95% 1.08-1.30, p<0.001) but improved if appropriate antibiotic changes were made within three days of intensive care unit admission (or 0.42, ci 95% 0.20-0.86, p=0.02). |
2005-09-08 |
2023-08-12 |
Not clear |
| R J Boots, J Lipman, R Bellomo, D Stephens, R E Helle. Predictors of physician confidence to diagnose pneumonia and determine illness severity in ventilated patients. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesthesia and intensive care. vol 33. issue 1. 2005-09-08. PMID:15957700. |
"life-threatening" pneumonia was predicted by worsening gas exchange (or 4.8, ci 95% 2.3-10.2, p<0.001), clinical signs of consolidation (or 2.0, ci 95% 1.2-3.2, p<0.01) and the sepsis-related organ failure assessment (sofa) score (or 1.1, ci 95% 1.1-1.2, p<0.001). |
2005-09-08 |
2023-08-12 |
Not clear |
| R J Boots, J Lipman, R Bellomo, D Stephens, R E Helle. Predictors of physician confidence to diagnose pneumonia and determine illness severity in ventilated patients. Australian and New Zealand practice in intensive care (ANZPIC II). Anaesthesia and intensive care. vol 33. issue 1. 2005-09-08. PMID:15957700. |
diagnostic confidence increased with cdis (or 16.3, ci 95% 8.4-31.4, p<0.001), definite pathogen isolation (or 3.3, ci 95% 2.0-5.6) and clinical signs of consolidation (or 2.1, ci 95% 1.3-3.3, p=0.001). |
2005-09-08 |
2023-08-12 |
Not clear |
| C S M Oude Nijhuis, J A Gietema, E Vellenga, S M G J Daenen, E S J M De Bont, W A Kamps, H J M Groen, E J van der Jagt, W T A van der Graa. Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patients. European journal of cancer (Oxford, England : 1990). vol 39. issue 17. 2004-01-12. PMID:14602135. |
we found that in only two of 109 (1.8%; 95% confidence interval (ci): 0.3-5.8%) febrile neutropenic episodes without clinical signs of new pulmonary disease, the cxr showed a consolidation suggesting pneumonia. |
2004-01-12 |
2023-08-12 |
Not clear |
| Carles Ariza-Cardenal, Manel Nebot-Adel. Factors associated with smoking progression among Spanish adolescents. Health education research. vol 17. issue 6. 2003-02-06. PMID:12507350. |
other predictors of consolidation included drinking alcohol (or = 3.1; 95% ci = 1.1-10.1) and reporting the intention to smoke in the future (or = 2.5; 95% ci = 1.3-4.9). |
2003-02-06 |
2023-08-12 |
Not clear |
| G Visani, R M Lemoli, A Isidori, P P Piccaluga, G Martinelli, M Malagola, L Gugliotta, A Bonini, F Bonifazi, M R Motta, S Rizzi, S Castellani, S Tur. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. Bone marrow transplantation. vol 27. issue 8. 2002-01-10. PMID:11477440. |
among the patients who received auto-sct, the double consolidation strategy produced a superior disease-free survival curve at 36 months (78.6% (95%ci: 59.4-97.8) vs 47.7% (95%ci: 33-62.4)) compared with the single-novia group. |
2002-01-10 |
2023-08-12 |
Not clear |
| T Mello E Souza, M R Vianna, C Rodrigues, J Quevedo, B A Moleta, I Izquierd. Involvement of the medial precentral prefrontal cortex in memory consolidation for inhibitory avoidance learning in rats. Pharmacology, biochemistry, and behavior. vol 66. issue 3. 2000-10-05. PMID:10899379. |
the results suggest that 1) the glutamatergic, gabaergic, and dopaminergic systems in fr2 are involved in the consolidation of memory for inhibitory avoidance learning, either directly or as parts of modulatory systems; and 2) timing of involvement of anterior fr2 (ci) is different from that of posterior fr2 (cii). |
2000-10-05 |
2023-08-12 |
rat |
| M S Tallman, P A Rowlings, G Milone, M J Zhang, W S Perez, D Weisdorf, A Keating, R P Gale, R B Geller, M J Laughlin, H M Lazarus, S M Luger, P L McCarthy, J M Rowe, R A Saez, M R Vowels, M M Horowit. Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood. vol 96. issue 4. 2000-09-07. PMID:10942365. |
five-year treatment-related mortality rates were 30% (95% confidence interval [ci], 18% to 42%) in patients receiving no consolidation chemotherapy, 22% (95% ci, 17% to 28%) in those receiving standard-dose cytarabine consolidation, and 24% (95% ci, 17% to 31%) in those receiving high-dose cytarabine (p = ns). |
2000-09-07 |
2023-08-12 |
human |
| H Tezcan, M J Barnett, C N Bredeson, D E Reece, J D Shepherd, B I Dalal, D E Horsman, H G Klingemann, S H Nantel, J J Spinell. Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992. Leukemia & lymphoma. vol 16. issue 5-6. 1995-07-24. PMID:7787754. |
the actuarial 2-year leukemia-free survival was 60% (95% ci 20-85%) for the 8 patients who underwent consolidation chemotherapy as planned and 53% (95% ci 68-86%) for the 5 patients who underwent allogeneic bmt in cr. |
1995-07-24 |
2023-08-12 |
Not clear |
| S Pavlovsky, I Fernández, V Palau, M T Santarelli, R De Bellis, G Ruiz-Argüelles, S Brandalise, E Jiménez-Fonsec. Combination of rubidazone and cytosine arabinoside in the treatment of first relapse in acute myelocytic leukemia. Annals of oncology : official journal of the European Society for Medical Oncology. vol 2. issue 6. 1992-02-27. PMID:1768631. |
induction consisted of 1-2 courses of rubidazone 200 mg/m2 days x 4 days plus cytosine arabinoside 100 mg/m2 x 7 days in ci followed by 2 consolidation courses of 3 days and 5 days. |
1992-02-27 |
2023-08-11 |
Not clear |